The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V
Abstract
PURPOSE: To review the importance of prognostic factors in developing new protocols for children with rhabdomyosarcoma (RMS). PATIENTS AND METHODS: Four studies conducted by the Intergroup Rhabdomyosarcoma Study (IRS) Group from 1972 through 1991. RESULTS: Favorable prognostic factors are: (1) undetectable distant metastases at diagnosis; (2) primary sites in the orbit and nonparameningeal head/neck and genitourinary nonbladder/prostate regions; (3) grossly complete surgical removal of localized tumor at the time of diagnosis; (4) embryonal/botryoid histology; (5) tumor size < or = 5 cm; and (6) age younger than 10 years at diagnosis. The IRS-V protocols are risk-based and refine therapy by reducing exposure to cyclophosphamide and radiation therapy (XRT) in patients at low risk while adding new, active agents such as topotecan or irinotecan to the standard therapy of vincristine, actinomycin D, and cyclophosphamide (VAC) plus XRT for patients with unfavorable histology or advanced disease. Collection of biologic specimens from patients with newly diagnosed disease continues to identify other factors that may distinguish patients with favorable features from those who need more intensive therapy. A new protocol that takes into account their previous treatment is needed for patients with recurrent disease. This program (being planned) does not include bone marrow/stem cell reconstitution because this strategy has thus far failed to improve survival rates of patients with metastases at diagnosis. CONCLUSION: Better understanding of biologic differences and new, active agents are needed to improve outcome of patients with unfavorable features at presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multicolor Spectral Karyotyping of Human Chromosomes
Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar-Am, I., Soenksen, D., et al. (1996) · Science · doi:10.1126/science.273.5274.494 · Cited by 1,755
The Third Intergroup Rhabdomyosarcoma Study.
Crist, W., Gehan, E. A., Ragab, A. H., Dickman, P. S., Donaldson, S. S., Fryer, C., Hammond, D., Hays, D. M., Herrmann, J., & Heyn, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.610 · Cited by 999
Self-citationMiser, J. S., Kinsella, T. J., Triche, T. J., Tsokos, M., Jarosinski, P., Forquer, R., Wesley, R., & Magrath, I. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1191 · Cited by 317
Crist, W. M., Garnsey, L., Beltangady, M. S., Gehan, E., Ruymann, F., Webber, B., Hays, D. M., Wharam, M., & Maurer, H. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.3.443 · Cited by 286
Self-citationPappo, A. S., Anderson, J. R., Crist, W. M., Wharam, M. D., Breitfeld, P. P., Hawkins, D., Raney, R. B., Womer, R. B., Parham, D. M., Qualman, S. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3487 · Cited by 275
Self-citationNewton, W. A., Soule, E. H., Hamoudi, A. B., Reiman, H. M., Shimada, H., Beltangady, M., & Maurer, H. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.1.67 · Cited by 267
Self-citationCommon and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly, K. M., Womer, R. B., Sorensen, P. H., Xiong, Q. B., & Barr, F. G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1831 · Cited by 203
Self-citationWolden, S. L., Anderson, J. R., Crist, W. M., Breneman, J. C., Wharam, Jr., Wiener, E. S., Qualman, S. J., & Donaldson, S. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3468 · Cited by 164
Self-citationWeber-Hall, S. J., Anderson, J., McManus, A. P., Abe, S., Nojima, T., Pinkerton, R., Pritchard‐Jones, K., & SHIPLEY, J. M. (1996) · PubMed · Cited by 159
Self-citationIn Vivo Amplification of the PAX3-FKHR and PAX7-FKHR Fusion Genes in Alveolar Rhabdomyosarcoma
Barr, F. G., Nauta, L. E., Davis, R. J., Schäfer, B. W., Nycum, L. M., & Biegel, J. A. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.15 · Cited by 151
Self-citation
Cited by
Rhabdomyosarcoma in adults: A retrospective analysis of 171 patients treated at a single institution
Ferrari, A., Dileo, P., Casanova, M., Bertulli, R., Meazza, C., Gandola, L., Navarria, P., Collini, P., Gronchi, A., Olmi, P., et al. (2003) · Cancer · doi:10.1002/cncr.11550 · Cited by 403
Arndt, C. A. S., Stoner, J. A., Hawkins, D. S., Rodeberg, D. A., Hayes-Jordan, A. A., Paidas, C. N., Parham, D. M., Teot, L. A., Wharam, M. D., Breneman, J. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3768 · Cited by 380
Self-citationMissiaglia, E., Williamson, D., Chisholm, J., Wirapati, P., Pierron, G., Petel, F., Concordet, J.-P., Thway, K., Oberlin, O., Pritchard-Jones, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5591 · Cited by 365
Stevens, M. C. G., Rey, A., Bouvet, N., Ellershaw, C., Flamant, F., Habrand, J. L., Marsden, H. B., Martelli, H., de Toledo, J. S., Spicer, R. D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.130 · Cited by 339
Classification of Rhabdomyosarcoma and Its Molecular Basis
Parham, D. M., & Barr, F. G. (2013) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3182a92d0d · Cited by 336
Self-citation
Metadata
- Authors
- Raney, R. B., Anderson, J. R., Barr, F. G., Donaldson, S. S., Pappo, A. S., Qualman, S. J., Wiener, E. S., Maurer, H. M., & Crist, W. M.
- Venue
- Journal of Pediatric Hematology/Oncology
- Published
- 2001-05
- Volume
- 23
- Issue
- 4
- Pages
- 215-220
- ISSN
- 0192-8562 (ISSN-L)
- OpenAlex
- W2324851880
- Cited by
- 376
- References
- 18
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V. https://app.cochat.ai/papers/10.1097/00043426-200105000-00008
- The paper
- Raney, R. B., Anderson, J. R., Barr, F. G., Donaldson, S. S., Pappo, A. S., Qualman, S. J., Wiener, E. S., Maurer, H. M., & Crist, W. M. (2001). Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V. Journal of Pediatric Hematology/Oncology. https://doi.org/10.1097/00043426-200105000-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.